3 employees
Drive Therapeutics is a new biotechnology company that strives to improve treatment for retinal diseases.
2019
$100K
from 1 investors over 1 rounds
Drive Therapeutics raised $100K on February 3, 2021
Investors: North Carolina Biotechnology Center (NCBiotech)